74 articles
AI tools in healthcare create hidden labor burdens for clinicians, who must verify outputs, correct bias, and apply judgment that algorithms cannot.
Healthcare AI success hinges on workflow fit and clinician trust, not flashy demos, experts say; one tool already saves the NHS 85,000 hours.
Over 80% of doctors use AI, but only 8% of patients trust it; here's how "human in the loop" could close that gap in your care.
AI scribes cut physician burnout by 21%, but some doctors warn the technology can strain the patient relationship it promises to improve.
Healthcare AI could cut preventable chronic disease by 2030, with IEEE ranking health tech above all other emerging technologies for human impact.
Universities are racing to close the AI healthcare skills gap by launching bioinformatics programs that blend computer science with biology for.
Tech giants like Google and Microsoft are now building AI healthcare tools alongside hospitals, with one Mayo Clinic study cutting treatment time by 76%.
Healthcare AI is delivering $3.20 per dollar spent in just 14 months, as hospitals race to deploy smarter diagnostics, drug discovery tools, and fertility.
A multicenter randomized trial shows AI-assisted diagnosis improves real-world accuracy for inherited retinal diseases, yet rigorous clinical evidence may.
Georgia Tech and the University of Alberta are investing millions in AI health centers to speed up disease diagnosis, drug discovery, and patient care.
The U.S. government is launching an expert sprint to create the first consensus standards for evaluating clinical AI before it reaches patients.
Foundation models merging genomic, imaging, and health record data are cutting drug development timelines and lifting diagnostic accuracy to 94% in cancer.
Healthcare AI could cut drug development costs by 50%, but experts say business models, not smarter tech, will decide if patients ever benefit.
AI and specialized logistics are reshaping drug discovery and healthcare delivery, from FedEx's $10B life sciences division to NHS AI tools cutting doctor.
Physician AI use jumped from 38% to 66% in just one year, and the tools winning adoption handle documentation and admin, not diagnosis.
Thomas Kannampallil will lead JAMIA in 2027, signaling that medical AI has shifted from research hype to real-world clinical deployment and patient safety.
AI healthcare breakthroughs are here now: tools detecting cancer non-invasively, diagnosing rare diseases, and saving doctors 30 minutes per patient visit.
Anthropic's Claude Science gives drug researchers 60+ AI tools to accelerate discovery, as the healthcare AI market races toward $744 billion by 2035.
Israel is investing NIS 70 million to build shared AI infrastructure that teaches machines to process biological data, targeting faster drug discovery and.
CellCarta's new AI consortium unites seven companies to help pharma sponsors validate and deploy digital pathology tools faster across drug development.
AI is reshaping healthcare by detecting stroke risk at home, predicting joint disease years early, and uncovering Alzheimer's drivers via blood biomarkers.
Healthcare cybersecurity's new frontier targets AI models and drug research, not just patient records, as attackers steal billions in scientific IP.
The National Academy of Medicine says decades-old patient safety rules can't govern AI, and is now drafting new conditions hospitals must meet before.
Doctors trusted faulty AI over clear patient evidence, revealing automation bias as a critical risk in clinical AI implementation.
China's new medical imaging AI platform cuts model development costs to one-tenth, aiming to make diagnostic AI accessible to hospitals worldwide.
Over 50% of clinicians prefer healthcare AI built by medical experts; trust and clinical validation now matter more than raw model power.
Mayo Clinic and GE HealthCare are using AI-powered imaging to personalize cancer treatment, potentially letting doctors pause radioligand therapy based on.
AI drug discovery has attracted $7 billion in investment, yet zero AI-discovered drugs are approved; the real bottleneck is clinical development, not.
AI can't fix clinical trials alone; without richer patient data capturing biological diversity, even the best algorithms will fail to improve drug.
FDA clears the first unified platform combining medical imaging, patient records, and AI, letting clinicians skip toggling between systems at the point of.
Geopolitical conflict is disrupting AI pathology's cloud infrastructure and supply chains, threatening a market projected to reach $68.81 million by 2035.
Healthcare AI jobs will grow 36% by 2033, and NEOMED's new MS program trains clinicians to deploy AI tools safely before hospitals face a workforce crisis.
Healthcare AI is racing toward $18.5 billion by 2034, but hospitals deploying diagnostic tools face unresolved liability, consent, and data privacy risks.
A University of Maryland AI tool scans patient records to catch missed pulmonary hypertension cases, flagging 382 patients in one test group alone.
China's new AI-powered cancer vaccine factory can personalize tumor treatment in 24 hours, a process that once took weeks or months.
AI drug discovery reached a human milestone as Insilico Medicine's AI-designed drug showed lung function gains in trials, while China races ahead with $30.
The FDA granted breakthrough status to two generative AI radiology tools that draft full chest X-ray reports, pushing clinical AI beyond detection into.
German researchers found medical AI models can expose anonymized patient data through membership inference attacks, with underrepresented groups facing.
UCLA Health's new INOVAi Center is rigorously testing healthcare AI in real-world clinical settings, with early trials showing AI scribes reduce physician.
Healthcare AI algorithms can boost clinical decisions without requiring coding skills; here is what every healthcare team needs to understand to evaluate.
Stanford's M-TRAM program is closing the translational medicine gap, training biomedical leaders to bridge lab discoveries and patient care in a $1.46T.
Japan is merging centuries-old Kampo medicine with AI and wearables to build a preventive healthcare system for its rapidly aging population.
Europe's 30 top health startups are using AI to detect sepsis, rare diseases, and cancer earlier, with some cutting diagnosis time from years to hours.
The University of Hawaii's new $12 million AI research hub aims to close critical health gaps for Pacific Islander populations often excluded from medical.
General-purpose AI chatbots are outperforming specialized clinical AI tools on physician benchmarks, while costing far less per patient.
Insilico Medicine and SK Biopharmaceuticals just formed a $2.5 billion AI drug discovery deal targeting neuroimmune disorders, aiming to cut discovery.
AI is closing three critical gaps in women's health care, catching missed diagnoses and fixing drug discovery data that excludes over 50% of patients.
An AI health tool caught four blood clots a chiropractor missed, sending one man to the ER in time to prevent a potentially fatal pulmonary embolism.
UK healthcare AI adoption doubled to 94% in one year, but experts warn rapid deployment risks data bias, over-diagnosis, and gaps in patient consent.
AI is set to transform drug discovery and medical diagnosis in 2026, cutting development timelines and helping clinicians catch diseases faster.
